What releases are required from the Area Developer and its affiliates as a condition of approval for a Learningrx transfer?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
- C.
The Area Developer and each of its affiliates, shareholders, members, partners, officers and directors must execute a general release, under seal, the consideration for which shall be the approval of the transfer, in a form satisfactory to Franchisor, of any and all claims against Franchisor and its affiliates, officers, directors, shareholders and employees, in their corporate and individual capacities, including, without limitation, claims arising under federal, state and local laws, rules and ordinances;
Source: Item 23 — RECEIPT (FDD pages 54–209)
What This Means (2025 FDD)
According to the 2025 Learningrx Franchise Disclosure Document, as a condition of approval for a transfer, the Area Developer and each of its affiliates, shareholders, members, partners, officers, and directors must execute a general release. This release must be under seal and in a form satisfactory to Learningrx. The consideration for this release is the approval of the transfer itself.
The general release covers any and all claims against Learningrx and its affiliates, officers, directors, shareholders, and employees, both in their corporate and individual capacities. This includes, but is not limited to, claims arising under federal, state, and local laws, rules, and ordinances. Essentially, by signing this release, the Area Developer and related parties waive their rights to sue Learningrx for any reason.
This requirement is a standard practice in franchising to protect the franchisor from potential future litigation related to the previous Area Developer's operation of the franchise. A prospective Learningrx franchisee should carefully review this requirement with legal counsel to fully understand the scope of the release and its implications before agreeing to a transfer.